Mattia Ferrarese Selected Research

Fabry Disease (Fabry's Disease)

1/2020

Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattia Ferrarese Research Topics

Disease

3	Hemophilia B (Haemophilia B) 01/2021 - 01/2017
2	Hemophilia A (Haemophilia) 01/2023 - 01/2019
2	Neoplasms (Cancer) 08/2021 - 01/2019
1	Ornithine Carbamoyltransferase Deficiency Disease 11/2020
1	Tyrosinemias (Tyrosinemia) 03/2020
1	Type 2 von Willebrand Disease 01/2020
1	Fabry Disease (Fabry's Disease) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017

Drug/Important Bio-Agent (IBA)

4	Factor IX (Coagulation Factor IX)FDA LinkGeneric 08/2021 - 01/2017
3	Nonsense Codon (Nonsense Mutation)IBA 01/2020 - 01/2017
1	AntibodiesIBA 01/2023
1	Factor VIII (Coagulation Factor VIII)IBA 01/2023
1	CoagulantsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 08/2021
1	neonatal Fc receptorIBA 01/2021
1	Human Serum Albumin FDA LinkGeneric 01/2021
1	U1 small nuclear RNAIBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 03/2020
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 03/2020
1	AntigensIBA 01/2020
1	CollagenIBA 01/2020
1	GalactosidasesIBA 01/2020
1	RistocetinIBA 01/2020
1	von Willebrand FactorIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	NucleotidesIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2018
1	antibiotic G 418IBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2017